To address what tumor-side molecular features may be driving the identification of low mast cells and thus perhaps the poor outcomes associated with depleted granulocytes, we compared the pretransplantation gene expression of the 328 patients for whom we had paired purified CD138+-selected samples and WBM samples. Here, SDC1 is linked to neoplasm.